Work

MPN-571 Effect of New or Worsening Anemia on Clinical Outcomes in Patients With Myelofibrosis (MF) Treated With Ruxolitinib (RUX): A Post Hoc Analysis of the COMFORT-I and -II Trials

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01259-4

Authors: Haifa Al-Ali, Ruben Mesa, J.E. Hamer-Maansson, Evan Braunstein, Claire Harrison

Institutions: University Hospital in Halle, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University, Incyte (United States), Guy's and St Thomas' NHS Foundation Trust

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4386271055

Cites:

Cited by:

Related to: 10